Hedge Fund - Orbis Investment Management
Elevance Health Inc. (ELV)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $1,239,276,288 | 7.09% | 2,849,173 | $401.43 |
| 2 | 2024 - Q4 (2024-12-31) | $800,123,810 | 4.3% | 2,168,945 | $418.46 |
| 3 | 2024 - Q3 (2024-09-30) | $470,546,440 | 2.49% | 904,897 | $534.22 |
| 4 | 2024 - Q2 (2024-06-30) | $501,106,168 | 3.12% | 924,789 | $528.58 |
| 5 | 2024 - Q1 (2024-03-31) | $497,359,715 | 2.97% | 959,154 | $497.33 |
| 6 | 2023 - Q4 (2023-12-31) | $425,161,325 | 2.66% | 901,606 | $462.41 |
| 7 | 2023 - Q3 (2023-09-30) | $385,708,534 | 2.77% | 885,831 | $453.58 |
| 8 | 2023 - Q2 (2023-06-30) | $332,956,701 | 2.38% | 749,413 | $461.32 |
| 9 | 2023 - Q1 (2023-03-31) | $316,592,979 | 2.48% | 688,530 | $475.89 |
| 10 | 2022 - Q4 (2022-12-31) | $301,698,689 | 2.39% | 588,141 | $507.74 |
| 11 | 2022 - Q3 (2022-09-30) | $318,272,000 | 2.6% | 700,671 | $478.49 |
| 12 | 2022 - Q2 (2022-06-30) | $372,250,000 | 2.99% | 771,374 | $494.71 |
| 13 | 2022 - Q1 (2022-03-31) | $644,942,000 | 4.7% | 1,312,939 | $457.10 |
| 14 | 2021 - Q4 (2021-12-31) | $712,151,000 | 5.26% | 1,536,331 | $420.70 |
| 15 | 2021 - Q3 (2021-09-30) | $640,489,000 | 4.39% | 1,718,049 | $380.04 |
| 16 | 2021 - Q2 (2021-06-30) | $819,194,000 | 5.17% | 2,145,610 | $382.16 |
| 17 | 2021 - Q1 (2021-03-31) | $885,633,000 | 6.33% | 2,467,287 | $321.58 |
| 18 | 2020 - Q4 (2020-12-31) | $959,036,000 | 6.94% | 2,986,815 | $306.88 |
| 19 | 2020 - Q3 (2020-09-30) | $931,999,000 | 7.33% | 3,469,971 | $269.07 |
| 20 | 2020 - Q2 (2020-06-30) | $885,339,000 | 6.66% | 3,366,565 | $266.78 |
| 21 | 2020 - Q1 (2020-03-31) | $708,860,000 | 6.94% | 3,122,181 | $272.52 |
| 22 | 2019 - Q4 (2019-12-31) | $694,004,000 | 4.84% | 2,297,796 | $275.19 |
| 23 | 2019 - Q2 (2019-06-30) | $601,473,000 | 4.32% | 2,131,295 | $273.16 |
| 24 | 2019 - Q1 (2019-03-31) | $561,215,000 | 3.8% | 1,955,588 | $289.21 |
| 25 | 2018 - Q4 (2018-12-31) | $545,469,000 | 3.92% | 2,076,948 | $274.98 |
| 26 | 2018 - Q3 (2018-09-30) | $649,207,000 | 3.72% | 2,368,937 | $259.59 |
| 27 | 2018 - Q2 (2018-06-30) | $583,541,000 | 3.24% | 2,451,542 | $231.57 |
| 28 | 2018 - Q1 (2018-03-31) | $532,771,000 | 3.04% | 2,424,994 | $234.91 |
| 29 | 2017 - Q4 (2017-12-31) | $547,252,000 | 3.21% | 2,432,125 | $212.98 |
| 30 | 2017 - Q3 (2017-09-30) | $551,601,000 | 3.4% | 2,904,999 | $190.32 |
| 31 | 2017 - Q2 (2017-06-30) | $799,933,000 | 5.02% | 4,252,021 | $179.68 |
| 32 | 2017 - Q1 (2017-03-31) | $674,089,000 | 4.6% | 4,075,998 | $159.07 |
| 33 | 2016 - Q4 (2016-12-31) | $448,585,000 | 3.21% | 3,120,155 | $133.90 |
| 34 | 2016 - Q3 (2016-09-30) | $266,147,000 | 1.86% | 2,123,907 | $129.12 |
| 35 | 2016 - Q2 (2016-06-30) | $123,063,000 | 0.93% | 936,984 | $136.83 |
| 36 | 2016 - Q1 (2016-03-31) | $10,847,000 | 0.08% | 78,040 | $133.63 |
The displayed share prices are average quarterly stock market prices.